SCHEMBL27537985

SCHEMBL27537985

C=CCCC(O)C(O)C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.36
USP2 O75604 3/20 0.36
CYP3A4 P08684 2/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
LMNA P02545 2/20 0.33
RECQL P46063 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
TSHR P16473 1/20 0.32
CYP2D6 P10635 1/20 0.31
NOS1 P29475 2/20 0.31
NOS3 P29474 1/20 0.31
NOS2 P35228 1/20 0.31
CTSK P43235 1/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27411781 0.81 ALDH1A1 (0.39) SMN1; SMN2USP2CYP3A4MAPTALDH1A1
SCHEMBL11066540 0.81 LMNA (0.35) SMN1; SMN2USP2CYP3A4MAPTALDH1A1
SCHEMBL29059466 0.80 TSHR (0.37) SMN1; SMN2USP2CYP3A4MAPTALDH1A1
SCHEMBL27408320 0.80 CYP2D6 (0.37) SMN1; SMN2USP2CYP3A4MAPTALDH1A1
SCHEMBL5026580 0.80 CYP2D6 (0.37) SMN1; SMN2USP2CYP3A4MAPTALDH1A1
SCHEMBL10965572 0.79 MEN1 (0.37) SMN1; SMN2USP2CYP3A4MAPTALDH1A1
SCHEMBL10166818 0.79 LTA4H (0.36) SMN1; SMN2USP2CYP3A4MAPTALDH1A1
SCHEMBL27664489 0.78 NOS1 (0.34) SMN1; SMN2USP2CYP3A4MAPTALDH1A1
SCHEMBL27604138 0.78 TDP1 (0.38) SMN1; SMN2USP2CYP3A4MAPTALDH1A1
SCHEMBL2332499 0.76 LMNA (0.39) SMN1; SMN2USP2CYP3A4MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105153110-A Synthetic method of atorvastatin calcium chiral intermediate UNIV HENAN NORMAL 2015-12-16 CN claimed
CN-101098859-A Pyrimidone compounds and preparation and application thereof ZHEJIANG HISUN PHARMACEUTICAL (CN) 2008-01-02 CN claimed
CN-103936680-B The preparation method of rosuvastain calcium known impurities 润泽制药(苏州)有限公司 2016-08-24 CN disclosed
CN-104230817-A Preparation method of 3, 5-dihydroxy-6-heptenoic acid derivatives NANJING MDC MEDICINE SCIENCE & TECHNOLOGY CO LTD 2014-12-24 CN disclosed
CN-102079726-B Miazine compounds, intermediates of miazine compounds, preparation method of intermediates and miazine compounds as well as application of miazine compound SHANGHAI INST PHARM INDUSTRY 2013-04-03 CN disclosed
CN-101967123-B 2-cyclopropyl-4-(N-methyl substituted anilino) quinoline compound as well as intermediate, preparation method and application thereof SHANGHAI INST PHARM INDUSTRY 2012-06-27 CN disclosed
CN-102079726-A Miazine compounds, intermediates of miazine compounds, preparation method of intermediates and miazine compounds as well as application of miazine compound SHANGHAI INST PHARM INDUSTRY 2011-06-01 CN disclosed
CN-101967123-A 2-cyclopropyl-4-(N-methyl substituted anilino) quinoline compound as well as intermediate, preparation method and application thereof SHANGHAI INST PHARM INDUSTRY 2011-02-09 CN disclosed
CN-101098859-A Pyrimidone compounds and preparation and application thereof ZHEJIANG HISUN PHARMACEUTICAL (CN) 2008-01-02 CN disclosed
CN-1088204-A 6-heptynoic acid and heptenoic acid compound SAGAMI CHEMICAL RESERCH CENTER (JP) 1994-06-22 CN disclosed